Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying

On February 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop as the first of a two-part series

Guides You on the Development and Implementation of B–R Evaluations Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and

Representing the first collection on the topic, this book builds from foundations to case studies, to future prospects, providing the reader with a rich and com

Risk assessment has been extensively developed in several scientific fields, such as environmental science, economics, and civil engineering, among others. In t